Selective GLS1 Inhibitors Show Potential in Treating Age-Associated Diseases

GLS1 inhibitors that remove senescent senescent cell selectively improved age-related tissue dysfunctions and diseases like arteriosclerosis

face_with_colon_three year 2021.

UTokyo People NAKANISH Makoto

UTokyo People JOHMURA Yoshikazu

Division of Cancer Cell Biology (IMSUT).

来源和详细信息:
https://www.ims.u-tokyo.ac.jp/imsut/en/about/press/page_00031.html

发表回复

您的电子邮箱地址不会被公开。 必填项已用 * 标注